Matches in DBpedia 2014 for { <http://dbpedia.org/resource/NXL103> ?p ?o. }
Showing items 1 to 21 of
21
with 100 items per page.
- NXL103 abstract "NXL103 (formerly XRP 2868) is an experimental drug candidate under development by Novexel. It is an oral streptogramin antibiotic that has potent in vitro activity against certain Gram positive bacteria including methicillin resistant Staphylococcus aureus (MRSA) as well as the important respiratory pathogens including penicillin-, macrolide- and quinolone-resistant strains. It is a combination of linopristin and flopristin.".
- NXL103 casNumber "642080-29-3".
- NXL103 wikiPageID "25020610".
- NXL103 wikiPageRevisionID "457331921".
- NXL103 casNumber "642080".
- NXL103 class "antibiotic".
- NXL103 component "Flopristin".
- NXL103 component "Linopristin".
- NXL103 hasPhotoCollection NXL103.
- NXL103 synonyms "NXL103; XRP 2868".
- NXL103 type "combo".
- NXL103 subject Category:Antibiotics.
- NXL103 type Drug.
- NXL103 type FunctionalSubstance.
- NXL103 comment "NXL103 (formerly XRP 2868) is an experimental drug candidate under development by Novexel. It is an oral streptogramin antibiotic that has potent in vitro activity against certain Gram positive bacteria including methicillin resistant Staphylococcus aureus (MRSA) as well as the important respiratory pathogens including penicillin-, macrolide- and quinolone-resistant strains. It is a combination of linopristin and flopristin.".
- NXL103 label "NXL103".
- NXL103 sameAs m.09gd04p.
- NXL103 sameAs Q15708453.
- NXL103 sameAs Q15708453.
- NXL103 wasDerivedFrom NXL103?oldid=457331921.
- NXL103 isPrimaryTopicOf NXL103.